Active Motif, Inc. develops and manufactures innovative kits, services and reagents for cell and molecular biology and is one of America’s fastest growing biotechnology companies. Our rapidly expanding product line has helped to build our reputation […
Azzur Group CA is seeking a Controls/Automation Specialist to support the controls department at a large biotech manufacturing/R&D site in Oceanside, CA. Prior controls and automation experience in the pharmaceutical and/or biotech industry is re […
We are searching for candidates with IN VIVO EXPERIENCE at all levels to join teams at thriving Biotech companies in San Diego. Cage Washers, Animal Technicians, Research Associates, and Postdocs/Scientist I’s needed. All candidates MUST HAVE IN VIVO […
Relational database development with oracle, or mySQL, and etc.- 5+ year working experience in pharmaceutical or biotech industry….From Indeed – Tue, 18 Oct 2016 19:57:57 GMT – View all San Diego jobs
*Position Summary: * * Support, management and maintenance of complex scientific systems with specific emphasis on the applications and environments thatFrom Indeed – Tue, 18 Oct 2016 14:36:36 GMT – View all San Diego jobs
Free Upcoming Learning Session to Raise Awareness about Breast Cancer and BRCA in Jewish Community
SAN FRANCISCO, Oct. 18, 2016 /PRNewswire-USNewswire/ — Congregation Emanu-El will host a Tauber Sponsored Program in partnership with Sherith Israel, the Kitchen, Congregation Beth Sholom, Sharsheret and the San Francisco Jewish Federation and Endowment Fund, and sponsored by the Laszlo N. Tauber Family Foundation on the subject of Jewish genetic testing for breast cancer on Sunday, October 30 at 9:30 am.
Learn more: http://www.emanuelsf.org/
Special guest speakers include Dr. Laura J. Esserman, MD, MBA, Director of the University of California at San Francisco Carol Franc Buck Breast Care Center at UC San Francisco and Dena Goldberg, MS, LCGC Genetic Counselor at the UCSF Cancer Genetics and Prevention Program at Mount Zion Hospital. Academy Award nominated documentary filmmaker (PROMISES) and BRCA-positive patient Justine Shapiro will also be in conversation with Dr. Esserman.
This is an event to broaden awareness of Jewish genetics and increased risks of cancer genes within the Jewish community. Dr. Esserman and Dena Goldberg will provide overviews about screening and genetic testing and insight into the latest research. This event is tailored to all genders (50% of those impacted by BRCA are men).
This event is free and open to the public.
Location: Congregation Emanu-El, 2 Lake street, San Francisco, CA, 94118
Laura J. Esserman, MD, MBA
Dr. Esserman is the Director of the UCSF Carol Franc Buck Breast Care Center at UC San Francisco, a professor of Surgery & Radiology, and a practicing surgeon and breast cancer oncology specialist. She is the founder of the University of California wide Athena Breast Health Network.
Dr. Esserman also leads the innovative clinical ISPY TRIALs, which are designed to accelerate the identification and approval of novel agents for women with high risk cancers.
Dena Goldberg M.S., LCGC Genetic Counselor
Dena Goldberg is a genetic counselor at the UCSF Cancer Genetics and Prevention Program at Mount Zion, where she sees patients and families at risk for hereditary cancer syndromes. Outside of her work at UCSF, Goldberg has a special interest in hereditary diseases and cancers affecting the Ashkenazi Jewish population, as well as chromosome 18 anomalies.
Goldberg has an M.S. in genetic counseling from UC Irvine and a B.S. in integrative biology from the University of Illinois Champaign-Urbana.
Rob Freedman/Byron Gordon
SOURCE Congregation Emanu-El
Coordinate and supervise the implementation of clinical studies. Polaris Pharmaceuticals, Inc….From Polaris Pharmaceuticals – Tue, 18 Oct 2016 13:15:52 GMT – View all San Diego jobs
SAN DIEGO, Oct. 18, 2016 /PRNewswire/ — Senomyx, Inc. (NASDAQ:SNMX) will release its financial results for the third quarter ended September 30, 2016 on Thursday, October 27, 2016, after the close of the U.S. financial markets. The Company will also host a conference call with a live Internet broadcast that will provide a corporate update and a review of its third quarter results on the same day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
To participate in the live conference call, U.S. residents should dial 844-825-0514, and international callers should dial 315-625-6892 at least 10 minutes prior to the call start time. The conference ID for this call is 88731344.
To access the live Internet broadcast or a subsequent archived recording, please log onto the Investor Relations section of Senomyx’s website at http://investor.senomyx.com. The archived webcast will be available for 30 days following the presentation. Please connect to Senomyx’s website prior to the start of the webcast to ensure adequate time to download any software that may be necessary.
About Senomyx, Inc. (www.senomyx.com)
Senomyx discovers novel flavor ingredients and natural high intensity sweeteners that allow food and beverage companies to create better-for-you products. Under its direct sales program, Senomyx sells its Complimyx® brand flavor ingredients, Sweetmyx®, Savorymyx®, and Bittermyx®, to flavor companies for use in a wide variety of foods and beverages. In addition, Senomyx has partnerships with leading global food, beverage, and ingredient supply companies, which are currently marketing products that contain Senomyx’s flavor ingredients. For more information, please visit www.senomyx.com.
Senior Vice President &
Chief Financial Officer
Five years ago, in November 2011, a company from Princeton, NJ, called Pharmasset shared news that would have an impact on millions of people around the world with hepatitis C. Its experimental drug…
[[Click headline to continue reading.]]
Masters in Health or Life Sciences.Training with direct applicability to biomedical and health research.Three (3) years experience with coordinating grant…From Scripps Health – Tue, 18 Oct 2016 10:28:07 GMT – View all La Jolla jobs